IS

Induprava Sahoo

Active Director Director DIN 07137478
DIN 07137478 First appointment Mar 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2015
Shareholding value •••• Premium profile

About Induprava Sahoo

Data last updated:

Induprava Sahoo is a Director at Jms Medicon Private Limited (since 2015). The company operates in Pharma. Jms Medicon Private Limited reported revenue of ₹7.46 Cr (FY 2024).

DIN 07137478
Primary Designation Director
Industry Pharma
First Appointment 25 Mar 2015
Oldest Company Age 16 yrs
Largest company Jms Medicon Private Limited · ₹7.46 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jms Medicon Private Limited U51397DL2010PTC204616
Director25 Mar 20152010₹7.46 Cr (FY 2024)Active

Board colleagues of Induprava Sahoo

NameDINCompanyDesignation
Udit Kumar Das03080401Jms Medicon Private LimitedDirector

Directorship timeline

Open interactive timeline →
Jms Medicon Private Limited
Premium access

Shareholding and investment profile for Induprava Sahoo

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Induprava Sahoo

Induprava Sahoo currently holds 1 directorship: Jms Medicon Private Limited (Director, since 25 Mar 2015, revenue ₹7.46 Cr (FY 2024)).

Induprava Sahoo was first appointed on 25 Mar 2015 as Director at Jms Medicon Private Limited.

The current boards of Induprava Sahoo's companies include Udit Kumar Das (Jms Medicon Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available